Literature DB >> 10645170

Clinically benign parotid tumours: local dissection as an alternative to superficial parotidectomy in selected cases.

B D Hancock1.   

Abstract

In a personal series of 162 tumours, 101 were pleomorphic adenomas 28 of which were removed by elective local extra capsular dissection and 73 by a conventional nerve dissection. There were no recurrences in either group after a mean follow-up 10.3 years, range 3-21 years for local dissection and 8.3 years, range 3-22 years for nerve dissection. Frey's syndrome did not occur after local dissection but was present in 25% of patients after a nerve dissection. Of the 162 parotid lumps, 17 proved to be a carcinoma but only one was deemed suitable for a local removal, a low grade muco epidermoid carcinoma of the accessory lobe and no recurrence has occurred after 8 years. In benign disease, local dissection gives similar results to conventional nerve dissection with less morbidity and confirms that tumour recurrence cannot be ascribed to any properties of the tumour but lies in the hands of the surgeon and depends on the care with which the tumour is removed.

Entities:  

Mesh:

Year:  1999        PMID: 10645170      PMCID: PMC2503303     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  5 in total

1.  The treatment of parotid tumours in the light of a pathological study of parotidectomy material.

Authors:  D H PATEY; A C THACKRAY
Journal:  Br J Surg       Date:  1958-03-18       Impact factor: 6.939

2.  Clinical significance of the tumour capsule in the treatment of parotid pleomorphic adenomas.

Authors:  M McGurk; A Renehan; E N Gleave; B D Hancock
Journal:  Br J Surg       Date:  1996-12       Impact factor: 6.939

3.  Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland.

Authors:  H Leverstein; J E van der Wal; R M Tiwari; I van der Waal; G B Snow
Journal:  Br J Surg       Date:  1997-03       Impact factor: 6.939

4.  Parotidectomy for parotid tumours: 19-year experience from The Netherlands.

Authors:  J M Debets; J D Munting
Journal:  Br J Surg       Date:  1992-11       Impact factor: 6.939

5.  Management of pleomorphic adenoma of the parotid.

Authors:  J D Maynard
Journal:  Br J Surg       Date:  1988-04       Impact factor: 6.939

  5 in total
  7 in total

Review 1.  Surgical options in benign parotid tumors: a proposal for classification.

Authors:  Miquel Quer; Vincent Vander Poorten; Robert P Takes; Carl E Silver; Carsten C Boedeker; Remco de Bree; Alessandra Rinaldo; Alvaro Sanabria; Ashok R Shaha; Albert Pujol; Peter Zbären; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-21       Impact factor: 2.503

2.  Safety of extracapsular dissection in benign superficial parotid lesions.

Authors:  F Riffat; A K Mahrous; M A Buchanan; B M Fish; P Jani
Journal:  J Maxillofac Oral Surg       Date:  2012-04-04

3.  Multinodular neck recurrence of parotid gland pleomorphic adenoma: a case report.

Authors:  Nick Papadogeorgakis; Evagelos F Kalfarentzos; Vassilis Petsinis; Eleni Parara; Maria-Emmanouela Kopaka
Journal:  Oral Maxillofac Surg       Date:  2011-06-10

Review 4.  Frey's Syndrome Consequent to an Unusual Pattern of Temporomandibular Joint Dislocation: Case Report with Review of Its Incidence and Etiology.

Authors:  Rajay A D Kamath; Shiva Bharani; Suhas Prabhakar
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2013-01-23

5.  Pleomorphic adenoma of the parotid gland: a 13-year experience of consequent management by lateral or total parotidectomy.

Authors:  Orlando Guntinas-Lichius; Carsten Kick; J Peter Klussmann; Markus Jungehuelsing; Eberhard Stennert
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-22       Impact factor: 2.503

6.  Clinical manifestations of recurrent parotid pleomorphic adenoma.

Authors:  Myung-Whan Suh; J Hun Hah; Seong Keun Kwon; Young-Ho Jung; Tack-Kyun Kwon; Kwang Hyun Kim; Myung-Whun Sung
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

Review 7.  PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients.

Authors:  Shang Xie; Kan Wang; Hui Xu; Rui-Xi Hua; Tian-Zhu Li; Xiao-Feng Shan; Zhi-Gang Cai
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.